Tricaprilin in Mild to Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2007-01-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and effectiveness of
tricaprilin administered once a day for ninety days in subjects with mild to moderate,
probable Alzheimer's disease.